Listed

LeonaBio, Inc.

LONANasdaqCIK 1620463HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$19.5m, Q2 FY2026
Net income−$19.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m27.2Research and development, Q3 FY2023, three months to 2023-09-30$27.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure23.7Research and development, Q4 FY2023, three months to 2023-12-31$23.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-27, accession 0000950170-25-029069. Derived: 12-month figure less the 9-month figure.Report this figure21.2Research and development, Q1 FY2024, three months to 2024-03-31$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure22.2Research and development, Q2 FY2024, three months to 2024-06-30$22.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure17.9Research and development, Q3 FY2024, three months to 2024-09-30$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure9.4Research and development, Q4 FY2024, three months to 2024-12-31$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure4.3Research and development, Q1 FY2025, three months to 2025-03-31$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure3.7Research and development, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure2.8Research and development, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure6.7Research and development, Q4 FY2025, three months to 2025-12-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure11.3Research and development, Q1 FY2026, three months to 2026-03-31$11.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure12.7Research and development, Q2 FY2026, three months to 2026-06-30$12.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Operating income$m(35.0)Operating income, Q3 FY2023, three months to 2023-09-30−$35.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure(29.0)Operating income, Q4 FY2023, three months to 2023-12-31−$29.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0000950170-25-029069. Derived: 12-month figure less the 9-month figure.Report this figure(27.7)Operating income, Q1 FY2024, three months to 2024-03-31−$27.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure(28.0)Operating income, Q2 FY2024, three months to 2024-06-30−$28.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure(29.6)Operating income, Q3 FY2024, three months to 2024-09-30−$29.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure(15.6)Operating income, Q4 FY2024, three months to 2024-12-31−$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Operating income, Q1 FY2025, three months to 2025-03-31−$9.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(7.3)Operating income, Q2 FY2025, three months to 2025-06-30−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure(6.9)Operating income, Q3 FY2025, three months to 2025-09-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure(78.6)Operating income, Q4 FY2025, three months to 2025-12-31−$78.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure(17.2)Operating income, Q1 FY2026, three months to 2026-03-31−$17.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(19.5)Operating income, Q2 FY2026, three months to 2026-06-30−$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(33.0)Net income, Q3 FY2023, three months to 2023-09-30−$33.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure(27.3)Net income, Q4 FY2023, three months to 2023-12-31−$27.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0000950170-25-029069. Derived: 12-month figure less the 9-month figure.Report this figure(26.3)Net income, Q1 FY2024, three months to 2024-03-31−$26.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure(26.9)Net income, Q2 FY2024, three months to 2024-06-30−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure(28.7)Net income, Q3 FY2024, three months to 2024-09-30−$28.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure(15.0)Net income, Q4 FY2024, three months to 2024-12-31−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Net income, Q1 FY2025, three months to 2025-03-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure(7.0)Net income, Q2 FY2025, three months to 2025-06-30−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure(6.6)Net income, Q3 FY2025, three months to 2025-09-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure(82.9)Net income, Q4 FY2025, three months to 2025-12-31−$82.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure(32.9)Net income, Q1 FY2026, three months to 2026-03-31−$32.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure(19.0)Net income, Q2 FY2026, three months to 2026-06-30−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Diluted EPS$ per share(0.87)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figurenot reported(0.69)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure(0.70)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure(7.46)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$7.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figurenot reported(2.34)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(1.78)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure(1.68)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figurenot reported(1.73)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(0.80)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Basic EPS$ per share(0.87)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.87 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figurenot reported(0.69)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure(0.70)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure(7.46)Basic EPS, Q3 FY2024, three months to 2024-09-30−$7.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figurenot reported(2.34)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(1.78)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure(1.68)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figurenot reported(1.73)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(0.80)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure

Balance sheet

Cash and equivalents$32.3m, Q2 FY2026
Shareholders' equity$33.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m110Cash and equivalents, Q3 FY2023, at 2023-09-30$110.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062082.Report this figure90.6Cash and equivalents, FY2023, at 2023-12-31$90.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029069.Report this figure77.8Cash and equivalents, Q1 FY2024, at 2024-03-31$77.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure73.8Cash and equivalents, Q2 FY2024, at 2024-06-30$73.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-01, accession 0000950170-24-089304.Report this figure68.9Cash and equivalents, Q3 FY2024, at 2024-09-30$68.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure48.4Cash and equivalents, FY2024, at 2024-12-31$48.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134565.Report this figure26.4Cash and equivalents, Q1 FY2025, at 2025-03-31$26.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure19.9Cash and equivalents, Q2 FY2025, at 2025-06-30$19.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure20.9Cash and equivalents, Q3 FY2025, at 2025-09-30$20.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure69.3Cash and equivalents, FY2025, at 2025-12-31$69.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure32.8Cash and equivalents, Q1 FY2026, at 2026-03-31$32.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure32.3Cash and equivalents, Q2 FY2026, at 2026-06-30$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Current assets$m179Current assets, Q3 FY2023, at 2023-09-30$178.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062082.Report this figure155Current assets, FY2023, at 2023-12-31$154.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029069.Report this figure129Current assets, Q1 FY2024, at 2024-03-31$128.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060482.Report this figure107Current assets, Q2 FY2024, at 2024-06-30$106.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089304.Report this figure82.0Current assets, Q3 FY2024, at 2024-09-30$82.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure54.8Current assets, FY2024, at 2024-12-31$54.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134565.Report this figure39.9Current assets, Q1 FY2025, at 2025-03-31$39.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure32.2Current assets, Q2 FY2025, at 2025-06-30$32.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure27.0Current assets, Q3 FY2025, at 2025-09-30$27.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure89.5Current assets, FY2025, at 2025-12-31$89.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure69.2Current assets, Q1 FY2026, at 2026-03-31$69.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure54.8Current assets, Q2 FY2026, at 2026-06-30$54.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Total assets$m185Total assets, Q3 FY2023, at 2023-09-30$184.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062082.Report this figure160Total assets, FY2023, at 2023-12-31$160.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029069.Report this figure133Total assets, Q1 FY2024, at 2024-03-31$133.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060482.Report this figure111Total assets, Q2 FY2024, at 2024-06-30$111.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0000950170-24-089304.Report this figure86.2Total assets, Q3 FY2024, at 2024-09-30$86.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure58.8Total assets, FY2024, at 2024-12-31$58.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-134565.Report this figure43.5Total assets, Q1 FY2025, at 2025-03-31$43.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure35.5Total assets, Q2 FY2025, at 2025-06-30$35.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure30.0Total assets, Q3 FY2025, at 2025-09-30$30.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure92.2Total assets, FY2025, at 2025-12-31$92.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure71.6Total assets, Q1 FY2026, at 2026-03-31$71.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure56.9Total assets, Q2 FY2026, at 2026-06-30$56.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Current liabilities$m28.6Current liabilities, Q3 FY2023, at 2023-09-30$28.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062082.Report this figure28.8Current liabilities, FY2023, at 2023-12-31$28.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029069.Report this figure25.6Current liabilities, Q1 FY2024, at 2024-03-31$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060482.Report this figure26.9Current liabilities, Q2 FY2024, at 2024-06-30$26.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089304.Report this figure27.8Current liabilities, Q3 FY2024, at 2024-09-30$27.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure13.1Current liabilities, FY2024, at 2024-12-31$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134565.Report this figure5.5Current liabilities, Q1 FY2025, at 2025-03-31$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure3.0Current liabilities, Q2 FY2025, at 2025-06-30$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure2.8Current liabilities, Q3 FY2025, at 2025-09-30$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure47.5Current liabilities, FY2025, at 2025-12-31$47.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure6.7Current liabilities, Q1 FY2026, at 2026-03-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure7.8Current liabilities, Q2 FY2026, at 2026-06-30$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Total liabilities$m29.9Total liabilities, Q3 FY2023, at 2023-09-30$29.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062082.Report this figure30.1Total liabilities, FY2023, at 2023-12-31$30.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029069.Report this figure26.7Total liabilities, Q1 FY2024, at 2024-03-31$26.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060482.Report this figure27.9Total liabilities, Q2 FY2024, at 2024-06-30$27.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0000950170-24-089304.Report this figure28.7Total liabilities, Q3 FY2024, at 2024-09-30$28.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure13.9Total liabilities, FY2024, at 2024-12-31$13.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001193125-26-134565.Report this figure6.2Total liabilities, Q1 FY2025, at 2025-03-31$6.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure3.6Total liabilities, Q2 FY2025, at 2025-06-30$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure3.2Total liabilities, Q3 FY2025, at 2025-09-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure64.4Total liabilities, FY2025, at 2025-12-31$64.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure22.3Total liabilities, Q1 FY2026, at 2026-03-31$22.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure23.3Total liabilities, Q2 FY2026, at 2026-06-30$23.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure
Shareholders' equity$m155Shareholders' equity, Q3 FY2023, at 2023-09-30$154.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure130Shareholders' equity, FY2023, at 2023-12-31$130.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-134565.Report this figure107Shareholders' equity, Q1 FY2024, at 2024-03-31$106.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure83.3Shareholders' equity, Q2 FY2024, at 2024-06-30$83.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure57.6Shareholders' equity, Q3 FY2024, at 2024-09-30$57.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure44.8Shareholders' equity, FY2024, at 2024-12-31$44.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure37.3Shareholders' equity, Q1 FY2025, at 2025-03-31$37.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure32.0Shareholders' equity, Q2 FY2025, at 2025-06-30$32.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure26.8Shareholders' equity, Q3 FY2025, at 2025-09-30$26.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure27.8Shareholders' equity, FY2025, at 2025-12-31$27.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure49.3Shareholders' equity, Q1 FY2026, at 2026-03-31$49.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure33.6Shareholders' equity, Q2 FY2026, at 2026-06-30$33.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure

Cash flow

Operating cash flow−$17.0m, Q2 FY2026
Capital expenditure$0, Q4 FY2024
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(24.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123372. Derived: 9-month figure less the 6-month figure.Report this figure(26.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$26.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0000950170-25-029069. Derived: 12-month figure less the 9-month figure.Report this figure(25.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$25.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure(22.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105052. Derived: 6-month figure less the 3-month figure.Report this figure(23.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269544. Derived: 9-month figure less the 6-month figure.Report this figure(26.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$26.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure(14.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(7.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001193125-26-352243. Derived: 6-month figure less the 3-month figure.Report this figure(4.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269544. Derived: 9-month figure less the 6-month figure.Report this figure(19.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figure(20.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$20.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure(17.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001193125-26-352243. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$30.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123372. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0000950170-25-029069. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$28.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105052. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269544. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001193125-26-134565. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)23.73m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares37.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3037,817,724 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062082.Report this figure37.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3137,923,402 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-060482.Report this figure38.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3037,999,578 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0000950170-24-089304.Report this figure38.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3038,054,583 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123372.Report this figure38.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3138,321,573 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0000950170-25-068040.Report this figure38.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3038,379,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105052.Report this figure3.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,851,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure3.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,904,244 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure3.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,909,297 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure3.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-303,943,887 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269544.Report this figure19.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3119,027,087 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211898.Report this figure23.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3023,726,211 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure

Shares outstanding: 9.42mShares outstanding, period not labelled, at 2026-08-049,421,663 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-352243.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.